Nicotine Pharmacokinetics and Pharmacodynamics, Safety and Tolerability of P3P

A Single-center, Open-label, Randomized, Crossover Study to Investigate the Nicotine Pharmacokinetic Profile, Pharmacodynamics, Safety and Tolerability of Four P3P Variants in Smoking Healthy Adult Subjects


Authored by  PMI

This is a single-center, open-label, randomized, crossover study to evaluate the pharmacokinetic (PK) profiles of four P3P variants, following a fixed puffing regimen and an ad libitum use period. In addition, pharmacodynamic (PD) effects (subjective effects and related behavioral assessments), as well as human puffing topography, will be evaluated, to provide further insights on product acceptance and product use.

Recruitment    Completed 
Study Results  No Results Available
 Enrollment  18
 Study Type  Interventional  (Clinical Trial)
 Other IDs  P3P-PK-01-CH